Patents by Inventor Christopher W. Seymour

Christopher W. Seymour has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Turbine Engine Abradable Systems
    Publication number: 20240158303
    Abstract: In a method for forming an abradable material (36), the abradable material has at least 20% by volume rutile titania (44) and hBN (46). The method includes: blending a first titania powder having an oxygen debit of at least 5.0% with a second titania powder having an oxygen debit, if any, of less than 1.0%. The blend is thermal sprayed. The sprayed blend is then oxidized.
    Type: Application
    Filed: March 24, 2022
    Publication date: May 16, 2024
    Applicant: RTX Corporation
    Inventors: Christopher W. Strock, Kevin C. Seymour
  • Metabolomics in pneumonia and sepsis
    Patent number: 10533989
    Abstract: The present invention describes a global metabolomic profile of patients with community acquired pneumonia (CAP) and sepsis. The metabolomic profile of endogenous small molecules blood was determined using mass-spectrometry. The global metabolomic profile in plasma demonstrated broad differences between CAP and sepsis patients when comparing those who do and do not survive at 90 days. Increases in specific metabolite biomarkers displayed on a heat map provide early diagnosis of these medical conditions to allow for early intervention and aggressive treatment.
    Type: Grant
    Filed: June 25, 2013
    Date of Patent: January 14, 2020
    Assignee: University Of Pittsburgh—Of The Commonwealth System Of Higher Education
    Inventors: John A. Kellum, Christopher W. Seymour
  • METABOLOMICS IN PNEUMONIA AND SEPSIS
    Publication number: 20150153331
    Abstract: The present invention describes a global metabolomic profile of patients with community acquired pneumonia (CAP) and sepsis. The metabolomic profile of endogenous small molecules blood was determined using mass-spectrometry. The global metabolomic profile in plasma demonstrated broad differences between CAP and sepsis patients when comparing those who do and do not survive at 90 days. Increases in specific metabolite biomarkers displayed on a heat map provide early diagnosis of these medical conditions to allow for early intervention and aggressive treatment.
    Type: Application
    Filed: June 25, 2013
    Publication date: June 4, 2015
    Inventors: John A. Kellum, Christopher W. Seymour